Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Waste of oral oncolytics and biologicals among users who discontinue therapy

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: BEKKER, Charlotte (Sint Maartenskliniek, Pharmacy, Nijmegen, Netherlands)
  • Co-author(s): Charlotte Bekker: Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands;Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands
    Helga Gardarsdottir: Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands;Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
    Eward Melis: Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands
    Toine Egberts: Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands;Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
    Marcel Bouvy: Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
    Bart van den Bemt: Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands;Pharmacy, Radboud University Medical Centre, Nijmegen, Netherlands
  • Abstract:

    Backgrounds

    Oral oncolytics and biological DMARDs (bDMARDs) are costly therapies. If patients stop their therapy it may lead to medication waste if drugs are taken from the pharmacy but left unused. 

    Aims

    We examined the proportion oral oncolytics and bDMARDs users who stop their therapy and have drugs leftover, the related costs, and the proportion

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses